glp-1 prescriptions q1 2025 growth Thinking about GLP-1s lately? In a new study, we analyzed ~1.4 million adults with sleep apnea from 2017β2025 and found: πΉ 6x increase in new πΉ14x increase in patients taking GLP-1 Market Trends and Global
Description
This gives providers the data to spot and address emerging imbalances early
When to seek medical attention Certain symptoms while taking Thrive GLP-1 warrant immediate medical evaluation

Tirzepatides dual action can cause more frequent gastrointestinal side effects (nausea and diarrhea)

More treatment options still need to be explored

Caffeine itself does not interfere with GLP-1 mechanism of action